Changes occurring on the cell surface during KSHV reactivation

Journal of Electron Microscopy

Volumn 56, Issue 1, 2007, Pages 27-36

  Whitman, Audy G ^a   Dyson, Ossie F ^a   Lambert, Phelps J ^a   Oxendine, Telisha L ^a   Ford, Patrick W ^a   Akula, Shaw M ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Egress; KSHV; Latency; SEM; Surface changes; TEM

Indexed keywords

PHORBOL 13 ACETATE 12 MYRISTATE; PRIMER DNA;

ARTICLE; CELL CYCLE; CELL LINE; CELL MEMBRANE; DRUG EFFECT; ELECTRON MICROSCOPY; GENETICS; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE; VIROLOGY; VIRUS ACTIVATION; VIRUS ASSEMBLY;

BASE SEQUENCE; CELL CYCLE; CELL LINE; CELL MEMBRANE; DNA PRIMERS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; MICROSCOPY, ELECTRON; MICROSCOPY, ELECTRON, SCANNING; POLYMERASE CHAIN REACTION; TETRADECANOYLPHORBOL ACETATE; VIRUS ACTIVATION; VIRUS ASSEMBLY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

CELL MEMBRANES; CYTOLOGY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; TOPOLOGY; VIRUSES;

CELL SURFACES; CELL-CYCLE PROGRESSION; EGRESS; INFECTED CELLS; KAPOSI’S SARCOMA-ASSOCIATED HERPES VIRUS; LATENCY; S-PHASE; SURFACE CHANGES; SURFACE TOPOLOGY; TEM;

SCANNING ELECTRON MICROSCOPY;

EID: 34047230803     PISSN: 00220744     EISSN: 14779986     Source Type: Journal    
DOI: 10.1093/jmicro/dfl041     Document Type: Article

References (43)

1. Ganem D (1998) Human herpesvirus 8 and its role in the genesis of Kaposi's sarcoma. Curr. Clin. Top. Infect. Dis. 18: 237-251.
2. Chang Y, Cesarman E, Pessin M S, Lee F, Culpepper J, Knowles D M, and Moore P S (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
3. Brown E E, Fallin M D, Goedert J J, Hutchinson A, Vitale F, Lauria C, Giuliani M, Marshall V, Mbisa G, Serraino D, Messina A, Durum S, Whitby D, and Chanock S J (2006) Host immunogenetics and control of human herpesvirus-8 infection. J. Infect. Dis. 193: 1054-1062.
4. Sarid R, Klepfish A, and Schattner A (2002) Virology, pathogenetic mechanisms, and associated diseases of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8). Mayo. Clin. Proc. 77: 941-949.
5. Simonart T (2006) Role of environmental factors in the pathogenesis of classic and African-endemic Kaposi's sarcoma. Cancer Lett. 244: 1-7.
6. Zong J C, Ciufo D M, Alcendor D J, Wan X, Nicholas J, Browning P J, Rady P L, Tyring S K, Orenstein J M, Rabkin C S, Su I J, Powell K F, Croxson M, Foreman K E, Nickoloff B J, Alkan S, and Hayward G S (1999) High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J. Virol. 73: 4156-4170.
7. Hamden K E, Whitman A G, Ford P W, Shelton J G, McCubrey J A, and Akula S M (2005) Raf and VEGF: emerging therapeutic targets in Kaposi's sarcoma-associated herpesvirus infection and angiogenesis in hematopoietic and nonhematopoietic tumors. Leukemia 19: 18-26.
8. Miller G, Heston L, Grogan E, Gradoville L, Rigsby M, Sun R, Shedd D, Kushnaryov V M, Grossberg S, and Chang Y (1997) Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J. Virol. 71: 314-324.
9. Cesarman E (2002) The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Recent Results Cancer Res. 159: 27-37.
10. Cook S D, Paveloff M J, Doucet J J, Cottingham A J, Sedarati F, and Hill J M (1991) Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants. Invest. Ophthalmol. Vis. Sci. 32: 1558-1561.
11. Glaser R, Kiecolt-Glaser J K, Speicher C E, and Holliday J E (1985) Stress, loneliness, and changes in herpesvirus latency. J. Behav. Med. 8: 249-260.
12. Blackbourn D J, Lennette E, Klencke B, Moses A, Chandran B, Weinstein M, Glogau R G, Witte M H, Way D L, Kutzkey T, Herndier B, and Levy J A (2000) The restricted cellular host range of human herpesvirus 8. Aids 14: 1123-1133.
13. Cerimele F, Curreli F, Ely S, Friedman-Kien A E, Cesarman E, and Flore O (2001) Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties. J. Virol. 75: 2435-2443.
14. Medveczky M M, Horvath E, Lund T, and Medveczky P G (1997) In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. Aids 11: 1327-1332.
15. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, and Ganem D (1996) Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2: 342-346.
16. Bryan B A, Dyson O F, and Akula S M (2006) Identifying cellular genes crucial for the reactivation of Kaposi's sarcoma-associated herpesvirus latency. J. Gen. Virol. 87: 519-529.
17. Cohen A, Brodie C, and Sarid R (2006) An essential role of ERK signalling in TPA-induced reactivation of Kaposi's sarcoma-associated herpesvirus. J. Gen. Virol. 87: 795-802.
18. Liang Y, and Ganem D (2003) Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling. Proc. Natl Acad. Sci. USA 100: 8490-8495.
19. McAllister S C, Hansen S G, Messaoudi I, Nikolich-Zugich J, and Moses AV (2005) Increased efficiency of phorbol ester-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus during S phase. J. Virol. 79: 2626-2630.
20. Tang W, and Newton R J (2005) Plant regeneration from callus cultures derived from mature zygotic embryos in white pine (Pinus strobus L.). Plant Cell Rep. 24: 1-9.
21. Ford P W, Hamden K E, Whitman A G, Bryan B A, Chintalgattu V, McCubrey J A, Dyson O F, and Akula S M (2005) Cigarette smoke concentrate inhibits Kaposi's sarcoma-associated herpesvirus infection. Virus Res. 114: 172-176.
22. McKelvey T A, Andrews S C, Miller S E, Ray C A, and Pickup D J (2002) Identification of the orthopoxvirus p4c gene, which encodes a structural protein that directs intracellular mature virus particles into A-type inclusions. J. Virol. 76: 11216-11225.
23. Toth S R (1981) Cell cycle-related morphological changes of feline lymphoid cells as revealed by electron microscopy. Cancer Res. 41: 4727-4736.
24. Krek W, and DeCaprio J A (1995) Cell synchronization. Methods Enzymol. 254: 114-124.
25. Powell C M, Rudge T L, Zhu Q, Johnson L F, and Hansen U (2000) Inhibition of the mammalian transcription factor LSF induces S-phase-dependent apoptosis by downregulating thymidylate synthase expression. EMBO J. 19: 4665-4675.
26. Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, and Strauss M (1999) NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol. Cell. Biol. 19: 2690-2698.
27. Mao Y, Wu J, Skog S, Eriksson S, Zhao Y, Zhou J, and He Q (2005) Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and cDNA profiling. Oncol. Rep. 13: 837-846.
28. Chang Z F, Huang D Y, and Chi L M (1998) Serine 13 is the site of mitotic phosphorylation of human thymidine kinase. J. Biol. Chem. 273: 12095-12100.
29. Gross M K, and Merrill G F (1989) Thymidine kinase synthesis is repressed in nonreplicating muscle cells by a translational mechanism that does not affect the polysomal distribution of thymidine kinase mRNA. Proc. Natl Acad. Sci. USA 86: 4987-4991.
30. Ohrvik A, Lindh M, Einarsson R, Grassi J, and Eriksson S (2004) Sensitive nonradiometric method for determining thymidine kinase 1 activity. Clin. Chem. 50: 1597-1606.
31. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny G D, Mitchison T J, Moskowitz M A, and Yuan J (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1: 112-119.
32. Zong W X, and Thompson C B (2006) Necrotic death as a cell fate. Genes Dev. 20: 1-15.
33. Akula S M, Pramod N P, Wang F Z, and Chandran B (2001) Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties. Virology 284: 235-249.
34. Dourmashkin R R, Bucher D, and Oxford J S (1993) Small virus-like particles bud from the cell membranes of normal as well as HIV-infected human lymphoid cells. J. Med. Virol. 39: 229-232.
35. Ford P W, Bryan B A, Dyson O F, Weidner D A, Chintalgattu V, and Akula S M (2006) Raf/MEK/ERK signalling triggers reactivation of Kaposi's sarcoma-associated herpesvirus latency. J. Gen. Virol. 87: 1139-1144.
36. Mettenleiter T C (2006) Intriguing interplay between viral proteins during herpesvirus assembly or: the herpesvirus assembly puzzle. Vet. Microbiol. 113: 163-169.
37. Mettenleiter T C (2002) Herpesvirus assembly, egress. J. Virol. 76: 1537-1547.
38. Saksena M M, Wakisaka H, Tijono B, Boadle R A, Rixon F, Takahashi H, and Cunningham A L (2006) Herpes simplex virus type 1 accumulation, envelopment, and exit in growth cones and varicosities in mid-distal regions of axons. J. Virol. 80: 3592-3606.
39. Hatano Y, Yoshida M, Uno F, Yoshida S, Osafune N, Ono K, Yamada M, and Nii S (2001) Budding of fowlpox and pigeonpox viruses at the surface of infected cells. J. Electron Microsc. (Tokyo) 50: 113-124.
40. Ravkov E V, Nichol S T, and Compans R W (1997) Polarized entry and release in epithelial cells of Black Creek Canal virus, a New World hantavirus. J. Virol. 71: 1147-1154.
41. Wong P K, and MacLeod R (1975) Studies on the budding process of a temperature-sensitive mutant of murine leukemia virus with a scanning electron microscope. J. Virol. 16: 434-442.
42. Le Blanc I, Prevost M C, Dokhelar M C, and Rosenberg A R (2002) The PPPY motif of human T-cell leukemia virus type 1 Gag protein is required early in the budding process. J. Virol. 76: 10024-10029.
43. Nicola A V, McEvoy A M, and Straus S E (2003) Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J. Virol. 77: 5324-5532.